{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:33:18Z","timestamp":1791135198637,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,3,14]]},"abstract":"<jats:p>A 45-year-old woman was diagnosed as having multiple endocrine neoplasia type 2A in 2014. She had bilateral pheochromocytoma, medullary thyroid carcinoma and biopsy-proven cutaneous lichen amyloidosis in the interscapular area. She underwent bilateral adrenalectomy; following which, she achieved clinical and biochemical remission. She was planned for total thyroidectomy at a later date; however, she was lost to follow-up. She presented to us again in December 2016 with abdominal pain. Examination revealed hypertension with postural drop. Positron emission tomography scan showed Ga<jats:sup>68<\/jats:sup> and fluorodeoxyglucose (FDG)-avid suprarenal, hepatic, peritoneal and mesenteric masses with abdominal lymph nodes. Twenty-four-hour urinary metanephrines\/normetanephrines were elevated. Serum calcitonin was as high as it was 2-1\/2 years ago. Ultrasonography-guided fine-needle aspiration cytology (FNAC) from the liver mass revealed neuroendocrine cells that did not stain for calcitonin. Hence, a diagnosis of metastatic pheochromocytoma was made. She underwent total thyroidectomy and was started on cyclophosphamide, vincristine, dacarbazine-based chemotherapy regimen.<\/jats:p>","DOI":"10.1136\/bcr-2017-222758","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T09:53:18Z","timestamp":1522230798000},"page":"bcr-2017-222758","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Metastatic pheochromocytoma in MEN 2A: A rare association"],"prefix":"10.1136","volume":"2018","author":[{"given":"Rimesh","family":"Pal","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashu","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bhansali","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1993.tb00350.x","article-title":"Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases","volume":"38","author":"Casanova","year":"1993","journal-title":"Clin Endocrinol"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group","volume":"238","author":"Modigliani","year":"1995","journal-title":"J Intern Med"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11581"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2368"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0667"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1653"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.7","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1440037"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000658-199306000-00001","article-title":"Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes","volume":"217","author":"Lairmore","year":"1993","journal-title":"Ann Surg"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1507\/endocrj.41.155","article-title":"A case of Sipple\u2019s syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine","volume":"41","author":"Sasaki","year":"1994","journal-title":"Endocr J"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.10","first-page":"305","article-title":"Brain metastasis from pheochromocytoma in a patient with multiple endocrine neoplasia type 2A","volume":"43","author":"Gentile","year":"2001","journal-title":"Panminerva Med"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/BF03347557","article-title":"Multiple endocrine neoplasia type 2A\/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma","volume":"28","author":"Gullu","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03164652","article-title":"Multiple endocrine neoplasia type 2 with malignant pheochromocytoma-long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy","volume":"6","author":"Namba","year":"1992","journal-title":"Ann Nucl Med"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.13","first-page":"827","article-title":"Pheochromocytoma: unusual presentation of a rare disease","volume":"4","author":"Hamdan","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF03350044","article-title":"Pre- and peroperative diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia type 2a","volume":"12","author":"Spapen","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0344-0338(00)80049-7","article-title":"Simultaneously occurring liver metastases of pheochromocytoma and medullary thyroid carcinoma-a diagnostic pitfall with clinical implications for patients with multiple endocrine neoplasia type 2a","volume":"196","author":"Hinze","year":"2000","journal-title":"Pathol Res Pract"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-4-267"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cen.12590","article-title":"Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature","volume":"82","author":"Deutschbein","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23812"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"2025082701294901000_2018.mar28_1.bcr-2017-222758.20","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyp005"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:30:01Z","timestamp":1756283401000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":20,"alternative-id":["10.1136\/bcr-2017-222758"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222758","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]}}}